Functional site of endogenous phospholipase A2 inhibitor from python serum

Area of Science:

• Biochemistry
• Pharmacology
• Immunology

Background:

• Secretory phospholipase A2 (sPLA2) enzymes play a role in inflammatory processes.
• Identifying specific inhibitors of sPLA2 is crucial for therapeutic development.

Purpose of the Study:

• To identify and characterize the functional site of a python phospholipase A2 inhibitor (PIP).
• To evaluate the anti-inflammatory potential of a synthetic peptide representing the predicted functional site.

Main Methods:

• Synthesis and testing of short peptides derived from PIP for sPLA2 inhibitory activity.
• In vitro enzymatic assays using various sPLA2s and [3H]arachidonate-labelled E. coli.
• In vivo studies including mouse paw edema model and rat postsurgical peritoneal adhesion model.

Main Results:

• A decapeptide, P-PB.III, demonstrated potent inhibition of sPLA2 enzymatic activity across different classes (I, II, III) and from human synovial fluid.
• P-PB.III exhibited significant anti-inflammatory effects in mouse and rat models, reducing edema and postsurgical adhesions.
• ELISA confirmed interaction between biotinylated P-PB.III and various PLA2s, indicating a key binding region.

Conclusions:

• The P-PB.III peptide represents a critical functional site of PIP involved in sPLA2 interaction.
• P-PB.III possesses significant anti-inflammatory properties and reduces sPLA2 levels in vivo.
• These findings provide a basis for designing novel therapeutic agents targeting sPLA2-mediated inflammation.